AADI Aadi Biosciences
- 3.390
- +1.070+46.12%
- 3.030
- -0.360-10.62%
Aadi Biosciences News
Aadi Bioscience, Inc.'s (NASDAQ:AADI) Shares Bounce 53% But Its Business Still Trails The Industry
Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Focus on Upcoming Inflation Report
Top Premarket Gainers
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Aadi Bioscience Rockets 72% on Key Updates
Express News | Kaken Pharmaceutical Co - to Acquire Aadi Subsidiary for $100 Mln
Express News | Aadi Bioscience Inc - Baiteng Zhao Appointed to Aadi Board of Directors
Express News | Aadi Bioscience Transforms With in-Licensing of Novel ADC Portfolio, $100 Million Sale of Fyarro® and $100 Million Pipe Financing
Aadi Bioscience Transforms With In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO and $100 Million PIPE Financing
Express News | Aadi Bioscience Inc : Jefferies Raises Target Price to $2 From $1.5
Aadi Biosciences | 10-Q: Q3 2024 Earnings Report
Aadi Biosciences | 8-K: Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
Express News | Aadi Bioscience Remains Actively Engaged In A Comprehensive Strategic Review To Maximize Shareholder Value
Express News | Aadi Bioscience Is Completing Wind-down Of PRECISION1 Trial Of Nab-sirolimus In Patients With Solid Tumors Harboring TSC1 Or TSC2 Inactivating Alterations
Aadi Bioscience GAAP EPS of -$0.46 In-line, Revenue of $7.21M Beats by $0.61M
Aadi Bioscience 3Q Loss/Shr 46c >AADI
Earnings Flash (AADI) AADI BIOSCIENCE Reports Q3 Revenue $7.2M
Express News | Aadi Bioscience Q3 Operating Expenses USD 20.625 Million
Express News | Aadi Bioscience Q3 Product Sales USD 7.212 Million
No Data
